Market revenue in 2023 | USD 18.0 million |
Market revenue in 2030 | USD 28.8 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Attenuated vaccine |
Fastest growing segment | DNA Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines |
Key market players worldwide | Lonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 30% in 2023. Horizon Databook has segmented the Argentina vaccine contract manufacturing market based on attenuated vaccine, inactivated vaccine, subunit vaccines, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Some of the major players in the Argentinean market include the National Administration of Laboratories and Health Institutes (ANLIS), the National Institute of Industrial Technology (INTI), and the National Institute of Agricultural Technology (INTA), which are all public institutions specialized in vaccine production.
The Argentinean government has implemented several initiatives to support the development and production of vaccines, including tax incentives and funding for R&D. This has encouraged local and international companies to invest in the Argentinean market.
In addition, in April 2017, ANMAT issued a new regulation that significantly reduces the timelines for approval of clinical trials. The new regulation would accelerate the evaluation process from 160 business days to 70 days or less. These factors can boost the country's contract development market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina vaccine contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Argentina vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account